Multiple sclerosis: Investigation into side effects of switching patients to natalizumab biosimilar Post date 26 February 2025 ← Bird flu: Two patients in US admitted to hospital with H5N1 as concerns over spread grow → Isle of Man poised to legalise assisted dying after vote